Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Anti-SARS-CoV-2 receptor binding domain antibodies after the second dose of Sinovac and AstraZeneca vaccination.

Marisca Evalina Gondokesumo,Anita Purnamayanti,Puri Safitri Hanum,Winnie Nirmala Santosa,Ardyan Prima Wardhana,Christina Avanti

Clinical and experimental vaccine research（2023）

Cited 1|Views4
No score
Abstract
Sinovac induced more significant titers of anti-SRBD IgG 1 month after the second dose but generated fewer AEFIs. In contrast, AstraZeneca generated more AEFIs, in mild to moderate severity, but provided lower levels of anti-SRBD IgG.
More
Translated text
Key words
astrazeneca vaccination,sinovac,antibodies,receptor,anti-sars-cov
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined